 |
| Proteomics Market |
Proteomics involves the study of proteomes which are the entire set of proteins produced or modified by an organism, system or biological context. Proteomics provide several advantages over genomics as it helps to better understand biological functions and dynamic changes that occur at the protein level in cells, tissues or body fluids. Proteomic technologies are increasingly being adopted in drug discovery and development process to generate comprehensive protein expression profiles from different diseases. It also aids in identifying novel biomarkers and drug targets. Adoption of proteomics in personalized medicine enables tailored treatment based on an individual's proteomic profile.
The global Proteomics Market is estimated to be valued at US$ 36.8 Bn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
Adoption of proteomics in drug discovery and personalized medicine is one of
the major trends fueling growth of the proteomics market. Proteomic
technologies helps in better understanding of disease mechanisms and biological
pathways. This aids researcher in identifying novel drug targets and
biomarkers. For instance, it is being widely used in cancer research to
understand cancer at protein level and identify personalized targets for
treatment. Growing applications of proteomics in precision medicine is expected
to drive significant market growth over the forecast period.
Segment
Analysis
The global proteomics market is dominated by the drug discovery segment. Next
generation protein sequencing and fragmentation techniques allow researchers to
identify disease biomarkers and potential drug targets. Mass spectrometry
proteomics has enabled high-throughput screening to identify protein-ligand
interactions critical for drug efficacy and safety assessments.
Key Takeaways
The global Proteomics
Market Share is expected to
witness high growth over the forecast period of 2023 to 2030 supported by
increasing government funding for proteomics research and growing applications
in precision medicine.
Regional analysis: North America currently accounts for the largest share of
the proteomics market owing to the strong presence of leading pharmaceutical
companies and research organizations. The region is anticipated tocontinue its
dominance led by the United States due to increasing research on proteome
analysis for chronic disease diagnostics and therapeutics. Asia Pacific is
poised to be the fastest growing regional market supported by rising R&D
expenditure, improving healthcare infrastructure and growing collaboration
between academia and industry in countries such as China and India.
Key players operating in the proteomics market are Super Vac, Ziamatic Corp.,
Akron Brass Company, Fire Hooks Unlimited, Inc., Tempest Technology
Corporation, CMC Rescue, Inc., SavaTech Corp., Water Rescue Innovations, RUTH
LEE Ltd., Mustang Survival, DURATEK Inc., Safety & Rescue Australia,
WernerCo, Sterling Rope Company, Inc., PETZL Distribution. Thermo Fisher
Scientific currently dominates the market with the widest proteomics product
portfolio comprising mass spectrometers, sample preparation kits and
bioinformatics software. Other major players include Danaher Corporation, Merck
KGaA, Agilent Technologies and Bruker Corporation.
For more insights, read- https://www.newsanalyticspro.com/proteomics-market-trends-size-and-share-analysis/
For more details on the report, Read- https://careersplay.com/the-rising-trend-of-biohacking-and-its-opportunities
0 Comments